A CSF‐restricted MOG‐IgG profile was observed in 22/405 (5%) of patients with a potential phenotype for MOGAD in a Japanese cohort and 2/99 (2%) MS patients.6 The gene discussed is MOG; the disease is myeloid sarcoma.